Combination Antiretroviral Therapy With Raltegravir Leads to Rapid Immunologic Reconstitution in Treatment-Naive Patients With Chronic HIV Infection | Zendy

Suresh Pallikkuth | Zendy; Margaret A. Fischl | Zendy; Savita Pahwa | Zendy

Open Access

Combination Antiretroviral Therapy With Raltegravir Leads to Rapid Immunologic Reconstitution in Treatment-Naive Patients With Chronic HIV Infection

Author(s) -

Suresh Pallikkuth,

Margaret A. Fischl,

Savita Pahwa

Publication year - 2013

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1093/infdis/jit387

Subject(s) - raltegravir , immune system , immunology , cd38 , medicine , viral load , cd8 , cart , cd14 , virology , virus , antiretroviral therapy , biology , mechanical engineering , stem cell , cd34 , engineering , genetics

In treatment-naive, human immunodeficiency virus (HIV)-infected persons, combination antiretroviral therapy (cART) incorporating raltegravir (RAL) is highly effective for virologic suppression, but characteristics of immunologic recovery have not been described.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research